New calculator predicts risk of early recurrence in patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality worldwide, with China accounting for over half of the global annual cases and deaths.

Novo Holdings is set to close its $16.5 billion acquisition of Catalent after FTC declines to challenge the deal

Novo Holdings, the parent company of Novo Nordisk, can proceed with its planned $16.5 billion acquisition of Catalent, a leading contract drug manufacturer, after U.S.

December 14, 2024

NHS data suggests inducing labor at 39 weeks may reduce inequalities in adverse outcomes

NHS data suggests inducing women with uncomplicated pregnancies at 39 weeks may reduce inequalities in adverse outcomes, according to a study by London School of

July 21, 2023

Probation disproportionately affects the health outcomes of Black Americans

“Mistrust all in whom the impulse to punish is powerful,” warned Friedrich Nietzsche more than a century ago.

September 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.